These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18715868)

  • 1. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease.
    Ju JS; Miller SE; Hanson PI; Weihl CC
    J Biol Chem; 2008 Oct; 283(44):30289-99. PubMed ID: 18715868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation.
    Bayraktar O; Oral O; Kocaturk NM; Akkoc Y; Eberhart K; Kosar A; Gozuacik D
    PLoS One; 2016; 11(10):e0164864. PubMed ID: 27768726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
    Ju JS; Weihl CC
    Hum Mol Genet; 2010 Apr; 19(R1):R38-45. PubMed ID: 20410287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.
    Tresse E; Salomons FA; Vesa J; Bott LC; Kimonis V; Yao TP; Dantuma NP; Taylor JP
    Autophagy; 2010 Feb; 6(2):217-27. PubMed ID: 20104022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
    Weihl CC; Miller SE; Hanson PI; Pestronk A
    Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of VCP in human neurodegenerative disorders.
    Kakizuka A
    Biochem Soc Trans; 2008 Feb; 36(Pt 1):105-8. PubMed ID: 18208395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ankrd13 Family of Ubiquitin-interacting Motif-bearing Proteins Regulates Valosin-containing Protein/p97 Protein-mediated Lysosomal Trafficking of Caveolin 1.
    Burana D; Yoshihara H; Tanno H; Yamamoto A; Saeki Y; Tanaka K; Komada M
    J Biol Chem; 2016 Mar; 291(12):6218-31. PubMed ID: 26797118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.
    Manno A; Noguchi M; Fukushi J; Motohashi Y; Kakizuka A
    Genes Cells; 2010 Aug; 15(8):911-22. PubMed ID: 20604808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
    Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
    Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
    Ju JS; Fuentealba RA; Miller SE; Jackson E; Piwnica-Worms D; Baloh RH; Weihl CC
    J Cell Biol; 2009 Dec; 187(6):875-88. PubMed ID: 20008565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valosin-Containing Protein (VCP)/p97 Oligomerization.
    Yu G; Bai Y; Zhang ZY
    Subcell Biochem; 2024; 104():485-501. PubMed ID: 38963497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.
    Song C; Wang Q; Song C; Lockett SJ; Colburn NH; Li CC; Wang JM; Rogers TJ
    Biochim Biophys Acta; 2015 Jan; 1853(1):222-32. PubMed ID: 25447673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.
    Weihl CC; Pestronk A; Kimonis VE
    Neuromuscul Disord; 2009 May; 19(5):308-15. PubMed ID: 19380227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.
    Wang T; Xu W; Qin M; Yang Y; Bao P; Shen F; Zhang Z; Xu J
    J Biol Chem; 2016 Jul; 291(27):14373-14384. PubMed ID: 27226613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
    Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
    PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalances in p97 co-factor interactions in human proteinopathy.
    Fernández-Sáiz V; Buchberger A
    EMBO Rep; 2010 Jun; 11(6):479-85. PubMed ID: 20414249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
    Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
    Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
    Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
    Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heavy metal cadmium induces valosin-containing protein (VCP)-mediated aggresome formation.
    Song C; Xiao Z; Nagashima K; Li CC; Lockett SJ; Dai RM; Cho EH; Conrads TP; Veenstra TD; Colburn NH; Wang Q; Wang JM
    Toxicol Appl Pharmacol; 2008 May; 228(3):351-63. PubMed ID: 18261755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.